| abstract |
A form of pharmacological dosage consisting of a substance, diluent or carrier that provides the non-specific modification of the antibody response to the antigen when given with a pharmacologically acceptable antigen, and provided with a pharmacologically acceptable antigen, is provided; 10% darifenacin or its pharmacologically acceptable salt in terms of weight for the lower gastrointestinal tract of the patient is determined by the dosage form. The formulation increases the bioavailability of darifenacin while minimizing undesired side effects. |